Herbal medicine Ninjinyoeito inhibits RANKL-induced osteoclast differentiation and bone resorption activity by regulating NF-kB and MAPK pathway DOI

Kaung Htike,

Kunihiro Yoshida,

Takanori Eguchi

et al.

Journal of Oral Biosciences, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Therapeutic Potential of Ginsenosides on Bone Metabolism: A Review of Osteoporosis, Periodontal Disease and Osteoarthritis DOI Open Access
S KO

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(11), P. 5828 - 5828

Published: May 27, 2024

Ginsenosides, bioactive compounds from the genus Panax, have potential therapeutic effects on diverse ailments, including diabetes. Emerging evidence suggests their involvement in bone metabolism. The present review summarizes current understanding of ginsenosides osteoporosis, periodontal disease, and osteoarthritis. Their mechanisms action include osteoblasts, osteoclasts, ligament fibroblasts (PDLFs), chondrocytes, which are pivotal maintaining bone, tissue, cartilage homeostasis. Ginsenosides may exert beneficial by enhancing PDLF osteoblast activity, suppressing osteoclast function, augmenting chondrocyte synthesis matrix, mitigating connective tissue degradation. Moreover, they possess antioxidant, anti-inflammatory, antimicrobial, anti-pyroptotic properties. efficacy increasing density, ameliorating periodontitis, alleviating osteoarthritis symptoms has been demonstrated preclinical studies using animal models. In terms mechanism action, modulate cellular differentiation, key signaling pathway molecules, such as mitogen-activated protein kinases (MAPKs), while also regulating various mediators. Furthermore, symptomatic relief observed models lends further credence to utility. However, translate these findings into clinical practice, rigorous investigations imperative ascertain safety, efficacy, optimal dosing regimens human subjects.

Language: Английский

Citations

5

Wnt5a exacerbates pathological bone features and trabecular bone loss in curdlan-injected SKG mice via osteoclast activation DOI Creative Commons
Min Whangbo,

Eunae Ko,

D. H. Kim

et al.

BMB Reports, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 13, 2025

Many studies on osteoblasts have suggested that Wnt5a plays a crucial role in excessive osteoblast activity, which is responsible for ectopic new bone formation, but research osteoclasts ankylosing spondylitis (AS) remains relatively limited.This study aimed to explore whether influences osteoclastmediated resorption curdlan-injected SKG mice, model mimics AS.Compared the Vehicle group, treatment group exhibited statistically higher clinical arthritis scores and increased hindpaw thickness values.Microcomputed tomography (microCT) analysis of hindpaws revealed significant increase inflamed density Wnt5a-treated compared group.Histological examination also showed pronounced inflammation structural damage marrow ankles group.Intriguingly, microCT femur trabecular loss was markedly observed group.Both number TRAP-positive their activity were greater group.Serum markers resorption, not significantly elevated group.Notably, promotion osteoclast differentiation by inhibited following with anti-Wnt5a.These findings suggest targeting could be promising strategy mitigating pathological features AS modulating activity.

Language: Английский

Citations

0

Research Progress of Traditional Chinese Medicine in the Treatment of Osteoporosis DOI Creative Commons

庆贺 孟

Advances in Clinical Medicine, Journal Year: 2025, Volume and Issue: 15(01), P. 90 - 97

Published: Jan. 1, 2025

Language: Английский

Citations

0

The chemicalome profiling of Zishen Yuzhen Pill in vivo and its promoting effect on osteogenic differentiation of MC3T3-E1 cells DOI Creative Commons
Juanjuan Cheng,

Xinyue Meng,

Daozheng Fang

et al.

Frontiers in Analytical Science, Journal Year: 2025, Volume and Issue: 5

Published: Feb. 19, 2025

Zishen Yuzhen Pill (ZYP) is a Chinese herbal product developed by Shenzhen TCM Hospital, which have been frequently used to treat osteoporosis (OP). This study aimed determine the major chemical components of ZYP and its prototype compounds metabolites in rat biological samples, as well explore potential effect ZYP-containing serum MC3T3-E1 cells. UPLC-Q/TOF-MS was identify components. Then, orally administered rat, samples plasma, urine, feces, bile, tissue were collected metabolites. The viability cells evaluated using CCK-8 method after treatment with various concentrations (2%, 4%, 8%) serum. Following serum, activity alkaline phosphatase (ALP) Alizarin red S (ARS) measured, levels Runx2, Opn, Opg Osterix quantified qPCR Western blot analysis. And for RNA-seq Results indicated that total 152 identified ZYP, including flavonoids, iridoid, lignans, triterpene saponins, etc. Furthermore, we detected 70 99 distributed different tissues. In addition, observably promoted osteogenesis increasing ALP ARS activities, up-regulating expression results beneficial effects may be related upregulation mitochondrial oxidative phosphorylation. work provided further support traditional application OP. this can promote pharmacokinetic pharmacological evaluation ZYP.

Language: Английский

Citations

0

Therapeutic effects of ginsenosides on osteoporosis for novel drug applications DOI Creative Commons
Rui Liu,

Lixia Xu,

Lin-Jian Tong

et al.

European Journal of Pharmacology, Journal Year: 2024, Volume and Issue: 974, P. 176604 - 176604

Published: April 20, 2024

Osteoporosis (OP) is a metabolic bone disease with high incidence rate worldwide. Its main features are decreased mass, increased fragility and deterioration of microstructure. It caused by an imbalance between formation resorption. Ginsenoside safe effective traditional Chinese medicine (TCM) usually extracted from ginseng plants, having various therapeutic effects, which the effect against osteoporosis has been extensively studied. We searched total 44 relevant articles using keywords including osteoporosis, ginsenosides, mesenchymal cells, osteoblasts, osteoclasts remodeling, all investigated cellular mechanisms different types ginsenosides affecting activity remodeling stem osteoblasts to counteract osteoporosis. This review describes used treat perspectives, providing solid theoretical basis for future clinical applications.

Language: Английский

Citations

1

Fu-zi decoction attenuate rheumatoid arthritis in vivo and in vitro by modulating RANK/RANKL signaling pathway DOI Creative Commons
Zhenzhen Pan,

Fangchan Li,

Yu-Jie Xu

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: July 23, 2024

Background Fu-zi decoction (FZD) has a long history of application for treating Rheumatoid arthritis (RA) as classic formulation. However, its underlying mechanisms have not been fully elucidated. This study aimed to decipher the potential mechanism FZD in RA, with specific focus on receptor activator nuclear factor κB/receptor κB ligand (RANK/RANKL) signaling pathway. Methods The impact RA was investigated collagen-induced rats (CIA), and an osteoclast differentiation cell model. In vivo , antiarthritic effect at various doses (2.3, 4.6, 9.2 g/kg/day) evaluated by index score, paw volume, toe thickness histopathological examination inflamed joints. Additionally, ankle joint tissues were determined micro-CT safranin O fast green staining evaluate synovial hyperplasia articular cartilage damage. vitro maturation TRAP RANKL-induced bone marrow mononuclear cells. levels pro- anti-inflammatory cytokines well RANKL OPG ELISA kits. addition, Western blotting used investigate RANK/RANKL pathway activation both . Results significantly diminished weigh loss CIA rats, alleviated pathological alterations. Consistent results, markedly inhibited decreasing numbers dose-dependent manner. Moreover, decreased pro-inflammatory IL-6, IL-1β TNF-α, while increasing cytokine IL-10 level serum culture supernatants. Treatment reduced levels, increased RANKL/OPG ratio. settings, downregulated protein expressions RANK, RANKL, c-Fos, elevating further Conclusion conclusion, exerts therapeutic inhibiting RANK/RANKL-mediated differentiation, which suggested that is promising treatment RA.

Language: Английский

Citations

0

Role of ginsenosides in bone remodelling: A narrative review on molecular mechanism DOI Open Access
Ankur Joshi, Soni Priyanka,

Verma Poojashree

et al.

International Journal of Pharmaceutical Chemistry and Analysis, Journal Year: 2024, Volume and Issue: 11(3)

Published: Sept. 15, 2024

Osteoporosis (OP) is a metabolic bone disease that impacts large number of humanity. Degeneration the microstructure, loss mass, and heightened fragility are symptoms. The primary reason because rates formation resorption different. Extensive research on effects ginsenoside, component ginseng used in traditional Indian medicine, osteoporosis has shown promising results. There were forty-four articles written about ginsenosides, osteoblasts, osteoclasts, osteoporosis, mesenchymal cells. ginsenosides osteoblast, osteoclast, stem cell activity remodelling their potential role preventing focus these studies. This in-depth study sheds light several to treat from different perspectives, paving way for therapeutic applications future.

Language: Английский

Citations

0

Herbal medicine Ninjinyoeito inhibits RANKL-induced osteoclast differentiation and bone resorption activity by regulating NF-kB and MAPK pathway DOI

Kaung Htike,

Kunihiro Yoshida,

Takanori Eguchi

et al.

Journal of Oral Biosciences, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

0